Global Gastric Cancer Diagnostic Market Size study, by Product (Reagents and Consumables, Instruments) by Disease Type (Adenocarcinoma, Gastric Lymphoma, Others), by End User (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers) and Regional Fo

Global Gastric Cancer Diagnostic Market Size study, by Product (Reagents and Consumables, Instruments) by Disease Type (Adenocarcinoma, Gastric Lymphoma, Others), by End User (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers) and Regional Forecasts 2022-2032

Global Gastric Cancer Diagnostic Market is valued approximately at USD 2.42 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.32% over the forecast period 2024-2032. Gastric cancer diagnostic encompasses a series of medical procedures, tests, and evaluations conducted by healthcare professionals to detect and confirm the presence of gastric cancer, also known as stomach cancer. These diagnostic methods include imaging studies, endoscopic examinations, biopsy, blood tests, and molecular profiling. The primary aim of gastric cancer diagnostics is to identify the disease at an early stage, accurately evaluate its extent and severity, and guide subsequent treatment decisions. Early diagnosis is critical, as it significantly impacts patient outcomes by enabling timely intervention and appropriate treatment.

The growth of the gastric cancer diagnostic market is propelled by an increase in rising incidences of gastric cancer and a surge in demand for advanced diagnostic tools for treatment. The rising prevalence of gastric cancer globally leads to a heightened need for diagnostic services, driving market expansion. Additionally, continuous technological advancements in endoscopy, molecular testing, and imaging techniques enhance the accuracy and efficiency of gastric cancer diagnosis, further fueling market growth. Moreover, increasing awareness about the importance of early diagnosis and the availability of gastric cancer diagnostic tools are driving forces in enhancing public health and cancer care. This growing awareness helps individuals understand the significance of early detection in combating gastric cancer, a disease that often remains asymptomatic until advanced stages, thus fueling market growth. However, the high cost of diagnostic tests can deter individuals from seeking early diagnosis, especially in regions with limited access to affordable healthcare, negatively impacting market growth. Concerns about financial burden may lead patients to postpone or avoid diagnostic tests, resulting in delayed diagnosis and more advanced disease stages at the time of diagnosis, thereby restraining market expansion.

The key regions considered for the Global Gastric Cancer Diagnostic Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the market in revenue attributed to its advanced healthcare infrastructure, higher incidence rates, extensive screening programs, focus on precision medicine, and a growing aging population. The presence of major players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and Agilent Technologies, Inc., also contributes to market growth in the region. Furthermore, the Asia-Pacific region is expected to grow at the highest rate during the forecast period.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd.

Abbott Laboratories

Agilent Technologies, Inc.

Fulgent Genetics

Exact Sciences Corporation

MiRXES Pte Ltd

Bio-Rad Laboratories, Inc.

Hipro Biotechnology Co., Ltd.

Endofotonics Pte Ltd

Qiagen NV

PerkinElmer, Inc.

Thermo Fisher Scientific Inc.

Becton, Dickinson and Company

Siemens Healthineers AG

Illumina, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product:
• Reagents and Consumables
• Instruments

By Disease Type:
• Adenocarcinoma
• Gastric Lymphoma
• Others

By End User:
• Hospitals
• Diagnostic Laboratories
• Diagnostic Imaging Centers

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico
• RoLA

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.